Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+10.5%
5Y CAGR+25.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+10.5%/yr
vs +68.4%/yr prior
5Y CAGR
+25.9%/yr
Recent deceleration
Acceleration
-57.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
7 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $54.25M | +1.0% |
| 2024 | $53.71M | +26.4% |
| 2023 | $42.49M | +5.7% |
| 2022 | $40.19M | +37.9% |
| 2021 | $29.15M | +70.2% |
| 2020 | $17.12M | +212.4% |
| 2019 | $5.48M | +9.6% |
| 2018 | $5.00M | - |